secwatch.observer — SEC 8-K summary
======================================

Issuer:     Royalty Pharma plc (RPRX)
CIK:        0001802768
Form:       8-K
Filed at:   2025-08-13T23:59:59+00:00
Accession:  0001193125-25-179892
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Henry Fernandez steps down as Lead Independent Director of Royalty Pharma board
-------------------------------------------------------------------------------

- Fernandez resigned effective August 13, 2025, after five years on the board.
- No disagreement with the company; departure is voluntary.
- Board thanks Fernandez for his service and contributions.
- Company intends to name a new Lead Independent Director in the near future.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802768/000119312525179892/0001193125-25-179892-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802768/000119312525179892/d930454d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-179892

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer